tiprankstipranks
Trending News
More News >
Ionis Pharmaceuticals Inc. (IONS)
:IONS
US Market

Ionis Pharmaceuticals (IONS) Ratios

Compare
1,360 Followers

Ionis Pharmaceuticals Ratios

IONS's free cash flow for Q1 2025 was $0.99. For the 2025 fiscal year, IONS's free cash flow was decreased by $ and operating cash flow was $-1.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
9.66 5.90 7.06 9.73 7.34
Quick Ratio
9.62 5.83 6.99 9.63 7.27
Cash Ratio
1.06 0.89 6.37 8.78 6.52
Solvency Ratio
-0.18 -0.13 -0.13 >-0.01 -0.30
Operating Cash Flow Ratio
-2.00 -0.69 -0.88 0.13 0.12
Short-Term Operating Cash Flow Coverage
0.00 -5.78 -36.41 8.73 0.12
Net Current Asset Value
$ 81.71M$ 38.47M$ 242.00M$ 505.00M$ 583.00M
Leverage Ratios
Debt-to-Assets Ratio
0.50 0.49 0.53 0.44 0.31
Debt-to-Equity Ratio
2.96 3.76 2.35 1.50 0.89
Debt-to-Capital Ratio
0.75 0.79 0.70 0.60 0.47
Long-Term Debt-to-Capital Ratio
0.75 0.82 0.67 0.60 0.43
Financial Leverage Ratio
5.91 7.73 4.42 3.38 2.84
Debt Service Coverage Ratio
-4.22 -4.93 -15.31 0.10 -1.20
Interest Coverage Ratio
-5.26 0.00 -50.60 -6.98 -3.82
Debt to Market Cap
0.24 0.25 0.22 0.27 0.12
Interest Debt Per Share
9.45 10.16 9.54 8.26 5.69
Net Debt to EBITDA
-2.97 -4.58 2.82 3.99K 10.59
Profitability Margins
Gross Profit Margin
97.75%98.84%97.61%98.64%98.35%
EBIT Margin
-56.24%-32.80%-43.47%-3.06%-17.61%
EBITDA Margin
-53.75%-29.20%-38.80%-0.03%-14.80%
Operating Profit Margin
-65.85%-44.91%-70.02%-3.70%-23.59%
Pretax Profit Margin
-64.70%-42.40%-43.95%-3.70%-23.32%
Net Profit Margin
-63.84%-46.50%-46.00%-3.58%-66.80%
Continuous Operations Profit Margin
-63.79%-46.50%-45.95%-3.53%-65.81%
Net Income Per EBT
98.68%109.68%104.65%96.67%286.47%
EBT Per EBIT
98.25%94.41%62.77%100.00%98.84%
Return on Assets (ROA)
-16.28%-12.25%-10.66%-1.11%-20.38%
Return on Equity (ROE)
-92.06%-94.72%-47.12%-3.76%-57.77%
Return on Capital Employed (ROCE)
-18.44%-13.92%-18.50%-1.27%-8.19%
Return on Invested Capital (ROIC)
-18.16%-14.95%-19.29%-1.22%-20.46%
Return on Tangible Assets
-16.28%-12.25%-10.66%-1.12%-20.62%
Earnings Yield
-7.71%-5.06%-5.04%-0.68%-6.17%
Efficiency Ratios
Receivables Turnover
0.00 8.06 22.99 13.09 9.57
Payables Turnover
0.92 0.35 0.78 0.92 0.70
Inventory Turnover
1.40 0.32 0.64 0.44 0.55
Fixed Asset Turnover
2.74 3.24 2.29 4.55 4.03
Asset Turnover
0.26 0.26 0.23 0.31 0.31
Working Capital Turnover Ratio
0.32 0.39 0.29 0.41 0.34
Cash Conversion Cycle
-134.92 141.15 123.09 456.00 183.12
Days of Sales Outstanding
0.00 45.31 15.88 27.89 38.15
Days of Inventory Outstanding
260.65 1.14K 574.43 823.11 668.10
Days of Payables Outstanding
395.57 1.04K 467.23 395.00 523.14
Operating Cycle
260.65 1.18K 590.31 851.00 706.26
Cash Flow Ratios
Operating Cash Flow Per Share
-3.16 -2.15 -1.93 0.22 0.26
Free Cash Flow Per Share
-3.59 -2.35 -2.08 0.09 -0.04
CapEx Per Share
0.42 0.20 0.14 0.13 0.29
Free Cash Flow to Operating Cash Flow
1.13 1.09 1.07 0.42 -0.14
Dividend Paid and CapEx Coverage Ratio
-7.45 -10.98 -13.65 1.72 0.87
Capital Expenditure Coverage Ratio
-7.45 -10.98 -13.65 1.72 0.87
Operating Cash Flow Coverage Ratio
-0.36 -0.21 -0.20 0.03 0.05
Operating Cash Flow to Sales Ratio
-0.70 -0.39 -0.47 0.04 0.05
Free Cash Flow Yield
-9.56%-4.64%-5.50%0.30%-0.07%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-12.96 -19.75 -19.84 -147.97 -16.21
Price-to-Sales (P/S) Ratio
8.30 9.18 9.13 5.30 10.83
Price-to-Book (P/B) Ratio
12.48 18.71 9.35 5.56 9.36
Price-to-Free Cash Flow (P/FCF) Ratio
-10.46 -21.56 -18.19 332.71 -1.53K
Price-to-Operating Cash Flow Ratio
-11.83 -23.53 -19.53 139.33 219.93
Price-to-Earnings Growth (PEG) Ratio
-7.88 -0.57 -0.02 1.57 0.06
Price-to-Fair Value
12.48 18.71 9.35 5.56 9.36
Enterprise Value Multiple
-18.41 -36.04 -20.70 -13.96K -62.57
Enterprise Value
7.10B 8.29B 4.72B 3.34B 6.75B
EV to EBITDA
-18.41 -36.04 -20.70 -13.96K -62.57
EV to Sales
9.90 10.52 8.03 4.12 9.26
EV to Free Cash Flow
-12.47 -24.70 -16.01 258.74 -1.31K
EV to Operating Cash Flow
-14.15 -26.95 -17.19 108.36 188.08
Tangible Book Value Per Share
3.00 2.70 4.04 5.27 5.84
Shareholders’ Equity Per Share
3.00 2.70 4.04 5.47 6.04
Tax and Other Ratios
Effective Tax Rate
0.01 -0.10 -0.05 0.03 -1.86
Revenue Per Share
4.52 5.51 4.14 5.74 5.22
Net Income Per Share
-2.89 -2.56 -1.90 -0.21 -3.49
Tax Burden
0.99 1.10 1.05 0.97 2.86
Interest Burden
1.15 1.29 1.01 1.21 1.32
Research & Development to Revenue
1.24 1.14 1.42 0.79 0.73
SG&A to Revenue
0.21 0.30 0.26 0.21 0.49
Stock-Based Compensation to Revenue
0.18 0.13 0.17 0.15 0.32
Income Quality
1.10 0.84 1.02 -1.08 -0.07
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis